Lakhmir S. Chawla
Chief Medical Officer, La Jolla Pharmaceutical Company.
Companies
- REVELATION BIOSCIENCES, INC.Board member Oct 2, 2023 to now1
- La Jolla Pharmaceutical CompanyChief Medical Officer Jul 8, 2015 to Sep 17, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- REVELATION BIOSCIENCES, INC. REVB44,169 shares3$20.7K at $0.47Aug 17, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 17, 2026Granted 32,011 shares of REVELATION BIOSCIENCES, INC.3
- Feb 3, 2026Shares withheld for tax 2,261 shares at $1.85 of REVELATION BIOSCIENCES, INC.4
- Jan 8, 2026Granted 41,981 shares at $0.90 of REVELATION BIOSCIENCES, INC.5
- Oct 29, 2025Granted 15,625 shares at $1.28 of REVELATION BIOSCIENCES, INC.6
- Feb 11, 2025Granted 181 shares at $3.87 of REVELATION BIOSCIENCES, INC.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 5, 2026
- 5SEC EDGARForm 4 filed Jan 12, 2026
- 6SEC EDGARForm 4 filed Oct 31, 2025
- 7SEC EDGARForm 4 filed Feb 13, 2025